CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

@inproceedings{RIC2002CHOPCP,
  title={CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma},
  author={RIC and EPAGE and OSETTE and RI{\`E}RE and AOUL and ERBRECHT and ERV{\'E} and ILLY and Eda and OUABDALLAH and IERRE and OREL and HILIPPE and AULARD and HRISTIAN and ISSELBRECHT},
  year={2002}
}
  • RIC, EPAGE, +13 authors ISSELBRECHT
  • Published 2002
A BSTRACT Background The standard treatment for patients with diffuse large-B-cell lymphoma is cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP). Rituximab, a chimeric monoclonal antibody against the CD20 B-cell antigen, has therapeutic activity in diffuse large-B-cell lymphoma. We conducted a randomized trial to compare CHOP chemotherapy plus rituximab with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. Methods Previously untreated patients with diffuse… CONTINUE READING
Highly Influential
This paper has highly influenced 129 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS
Related Discussions
This paper has been referenced on Twitter 11 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 1,701 extracted citations

A Review of Autologous Stem Cell Transplantation in Lymphoma.

Current hematologic malignancy reports • 2017
View 5 Excerpts
Highly Influenced

Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2005
View 9 Excerpts
Highly Influenced

Cancer and AIDS

Springer International Publishing • 2019
View 5 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 27 references

Good clinical practice for trials on medicinal products in the European community

ES Jaffe, NL Harris, H Stein, JW Vardiman
World Health Organization classification of tumours : pathology and genetics of tumours of haematopoietic and lymphoid tissues • 2001

World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues

ES Jaffe, NL Harris, H Stein, JW. Vardiman
Lyon, France: International Agency for Research on Cancer, • 2001

A randomized comparison of ACVBP and CHOP in the treatment of advanced aggressive nonHodgkin’s lymphoma: the LNH93-5 study

H Tilly, E Lepage, B Coiffier
Blood 2000;96:832a. abstract • 2000

MabThera (rituximab) plus CHOP is superior to CHOP alone in elderly patients with diffuse large B-cell lymphoma (DLCL): interim results of a randomized GELA trial

B Coiffier, E Lepage, R Herbrecht
Blood 2000;96:223a. abstract • 2000

CHOP versus MACOP-B in aggressive lymphoma--a Nordic Lymphoma Group randomised trial.

Annals of oncology : official journal of the European Society for Medical Oncology • 1999

Similar Papers

Loading similar papers…